Why cancer rates are rising in young women—and what to do about it. A recent report found that women account for two-thirds of all cancers diagnosed in people under 50.

Objective To determine whether new users of proton pump inhibitors (PPIs) are at an increased risk of gastric cancer compared with new users of histamine-2 receptor antagonists (H2RAs). Design Using ...

New treatment approaches are expanding the ways gastric cancer can be managed, with a focus on quality of life. Photos: Shutterstock, Icon Cancer Centre. New: You can now listen to articles.

FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer By Angus Liu Jun 9, 2025 10:50am Merck & Co. Keytruda Bristol Myers Squibb Opdivo ...

It has been acknowledged that circulating tumor cells (CTCs) are promising biomarkers in liquid biopsy for cancer diagnosis and prognosis. However, the relationship between the CTC number and gastric ...

Claudin-18 isoform 2 (CLDN18.2) has emerged as a promising therapeutic target in gastric or gastro-oesophageal junction cancer. Satricabtagene autoleucel (satri-cel; also known as CT041), an ...

For this trial, 474 people with stomach or esophageal cancer were randomly assigned to take either durvalumab or a placebo alongside the standard chemotherapy brew used to treat these cancers.

norfolkdailynews.com 525 Norfolk Avenue Norfolk, NE 68701 Phone: (402)371-1020 Email: [email protected] ...

When combined with chemo, durvalumab eliminated cancer in nearly 1 in 5 patients. After two years, more than two-thirds were still alive. FRIDAY, June 6, 2025 (HealthDay News) — Immunotherapy combined ...

SEATTLE — June 4, 2025 — Below are summaries of recent Fred Hutch Cancer Center research findings, patient stories and other news. Check out a video of Fred Hutch Advanced Practice Providers (APPs) ...

Inflammation fuels the high rate of cancer in people over 50, researchers find, leading them to test anti-inflammatories like allergy drugs to fight it.